Alternative Non-Drug Treatment Options of the Most Neglected Parasitic Disease Cutaneous Leishmaniasis: A Narrative Review
- PMID: 37235323
- PMCID: PMC10223966
- DOI: 10.3390/tropicalmed8050275
Alternative Non-Drug Treatment Options of the Most Neglected Parasitic Disease Cutaneous Leishmaniasis: A Narrative Review
Abstract
With more than 12 million cases worldwide, leishmaniasis is one of the top 10 neglected tropical diseases. According to the WHO, there are approximately 2 million new cases each year in foci in around 90 countries, of which 1.5 million are cutaneous leishmaniasis (CL). Cutaneous leishmaniasis (CL) is a complex cutaneous condition that is caused by a variety of Leishmania species, including L. (Leishmania) major, L. (L) tropica, L. (L) aethiopica, L. (L) mexicana, L. (Viannia) braziliensis, and L. (L) amazonensis. The disease imposes a significant burden on those who are affected since it typically results in disfiguring scars and extreme social stigma. There are no vaccines or preventive treatments available, and chemotherapeutic medications, including antimonials, amphotericin B, miltefosine, paromomycin, pentamidine, and antifungal medications, have a high price tag, a significant risk of developing drug resistance, and a variety of systemic toxicities. To work around these limitations, researchers are continuously looking for brand-new medications and other forms of therapy. To avoid toxicity with systemic medication use, high cure rates have been observed using local therapy techniques such as cryotherapy, photodynamic therapy, and thermotherapy, in addition to some forms of traditional therapies, including leech and cauterization therapies. These CL therapeutic strategies are emphasized and assessed in this review to help with the process of locating the appropriate species-specific medicines with fewer side effects, lower costs, and elevated cure rates.
Keywords: cauterization therapy; cryotherapy; cutaneous leishmaniasis; laser therapy; leech therapy; photodynamic therapy; thermotherapy.
Conflict of interest statement
The authors declare no conflict of interest.
Figures
Similar articles
-
Treatment of Cutaneous Leishmaniasis Caused by Leishmania aethiopica: A Systematic Review.PLoS Negl Trop Dis. 2016 Mar 3;10(3):e0004495. doi: 10.1371/journal.pntd.0004495. eCollection 2016 Mar. PLoS Negl Trop Dis. 2016. PMID: 26938448 Free PMC article. Review.
-
Interventions for American cutaneous and mucocutaneous leishmaniasis.Cochrane Database Syst Rev. 2020 Aug 27;8(8):CD004834. doi: 10.1002/14651858.CD004834.pub3. Cochrane Database Syst Rev. 2020. PMID: 32853410 Free PMC article.
-
[Diagnosis and therapy of cutaneous and mucocutaneous Leishmaniasis in Germany].J Dtsch Dermatol Ges. 2011 Nov;9 Suppl 8:1-51. doi: 10.1111/j.1610-0379.2011.07820.x. J Dtsch Dermatol Ges. 2011. PMID: 22050890 German.
-
Interventions for Old World cutaneous leishmaniasis.Cochrane Database Syst Rev. 2017 Nov 17;11(11):CD005067. doi: 10.1002/14651858.CD005067.pub4. Cochrane Database Syst Rev. 2017. Update in: Cochrane Database Syst Rev. 2017 Dec 01;12:CD005067. doi: 10.1002/14651858.CD005067.pub5. PMID: 29149474 Free PMC article. Updated. Review.
-
Interventions for Old World cutaneous leishmaniasis.Cochrane Database Syst Rev. 2017 Dec 1;12(12):CD005067. doi: 10.1002/14651858.CD005067.pub5. Cochrane Database Syst Rev. 2017. PMID: 29192424 Free PMC article. Review.
References
Publication types
Grants and funding
LinkOut - more resources
Full Text Sources